Log In
Print
BCIQ
Print
Print this Print this
 

BRCA MASTR Dx test

  Manage Alerts
Collapse Summary General Information
Company Multiplicom N.V.
DescriptionMolecular diagnostic assay
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify mutations in breast cancer 1 early onset (BRCA1) and BRCA2 genes in patients with increased risk for breast, ovarian and related cancers.
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today